Endo Pharmaceuticals Shares Down 45.0% Since SmarTrend's Sell Call (ENDP)

SmarTrend identified a Downtrend for Endo Pharmaceuticals (NASDAQ:ENDP) on April 29th, 2016 at $27.56. In approximately 3 weeks, Endo Pharmaceuticals has returned 44.98% as of today's recent price of...